Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF Treatment for Knee Osteoarthritis
NCT04749758Completed
- Sponsor
- University of Andorra
- Start
- Sep 2018
- Primary completion
- Dec 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of Celstem in knee osteoarthritis (OA), sponsored by University of Andorra. Primary endpoint: Visual Analogue Scale for Pain at 1 year. Started Sep 2018; status: completed.
02
Drugs
Celstem
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04749758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04749758.